The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Tenofovir disoproxil. The metabolism of Pomalidomide can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Nabumetone is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Zomepirac is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tenofovir disoproxil. The metabolism of Zolmitriptan can be decreased when combined with Tenofovir disoproxil. The metabolism of Mexiletine can be decreased when combined with Tenofovir disoproxil. The metabolism of Propafenone can be decreased when combined with Tenofovir disoproxil. The serum concentration of Tenofovir disoproxil can be increased when it is combined with Rilpivirine. The risk or severity of adverse effects can be increased when Nepafenac is combined with Tenofovir disoproxil. The serum concentration of Tizanidine can be increased when it is combined with Tenofovir disoproxil. The metabolism of Riluzole can be decreased when combined with Tenofovir disoproxil. The metabolism of Cisapride can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tenofovir disoproxil. The metabolism of Rizatriptan can be decreased when combined with Tenofovir disoproxil. The metabolism of Imatinib can be decreased when combined with Tenofovir disoproxil. The metabolism of Clonidine can be decreased when combined with Tenofovir disoproxil. The metabolism of Albendazole can be decreased when combined with Tenofovir disoproxil. The metabolism of Maprotiline can be decreased when combined with Tenofovir disoproxil. The metabolism of Ergotamine can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Carbaspirin calcium is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when E-6201 is combined with Tenofovir disoproxil. The metabolism of Asenapine can be decreased when combined with Tenofovir disoproxil. The serum concentration of Paromomycin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Frovatriptan can be decreased when combined with Tenofovir disoproxil. The metabolism of Genistein can be decreased when combined with Tenofovir disoproxil. The metabolism of Oxtriphylline can be decreased when combined with Tenofovir disoproxil. The metabolism of Diphenhydramine can be decreased when combined with Tenofovir disoproxil. The metabolism of Caffeine can be decreased when combined with Tenofovir disoproxil. The metabolism of Apixaban can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Acemetacin is combined with Tenofovir disoproxil. The metabolism of Vadimezan can be decreased when combined with Tenofovir disoproxil. The metabolism of Conjugated estrogens can be decreased when combined with Tenofovir disoproxil. The metabolism of Thiothixene can be decreased when combined with Tenofovir disoproxil. The metabolism of Lidocaine can be decreased when combined with Tenofovir disoproxil. The metabolism of Propranolol can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Bromfenac is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Bufexamac is combined with Tenofovir disoproxil. The metabolism of Eltrombopag can be decreased when combined with Tenofovir disoproxil. The metabolism of Imipramine can be decreased when combined with Tenofovir disoproxil. The serum concentration of Daunorubicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Propofol can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Mizoribine is combined with Tenofovir disoproxil. The metabolism of Telithromycin can be decreased when combined with Tenofovir disoproxil. The metabolism of Selegiline can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Epirizole is combined with Tenofovir disoproxil. The serum concentration of Amikacin can be increased when it is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Alclofenac is combined with Tenofovir disoproxil. The metabolism of Desipramine can be decreased when combined with Tenofovir disoproxil. The serum concentration of Tenofovir disoproxil can be increased when it is combined with Ledipasvir. The serum concentration of Doxorubicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Bupropion can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Metamizole is combined with Tenofovir disoproxil. The metabolism of Methadone can be decreased when combined with Tenofovir disoproxil. The metabolism of Carvedilol can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Etofenamate is combined with Tenofovir disoproxil. The metabolism of Imiquimod can be decreased when combined with Tenofovir disoproxil. The therapeutic efficacy of Didanosine can be decreased when used in combination with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Tenofovir disoproxil. The metabolism of Clopidogrel can be decreased when combined with Tenofovir disoproxil. The metabolism of Menadione can be decreased when combined with Tenofovir disoproxil. The serum concentration of Tipranavir can be decreased when it is combined with Tenofovir disoproxil. The metabolism of Ropivacaine can be decreased when combined with Tenofovir disoproxil. The metabolism of Carmustine can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Clonixin is combined with Tenofovir disoproxil. The metabolism of Cinnarizine can be decreased when combined with Tenofovir disoproxil. The metabolism of Malathion can be decreased when combined with Tenofovir disoproxil. The metabolism of Lomefloxacin can be decreased when combined with Tenofovir disoproxil. The metabolism of Amiodarone can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Pirfenidone is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Antipyrine is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Floctafenine is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Tinoridine is combined with Tenofovir disoproxil. The metabolism of Betaxolol can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Mesalazine is combined with Tenofovir disoproxil. The metabolism of Enasidenib can be decreased when combined with Tenofovir disoproxil. The serum concentration of Amrubicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Tamoxifen can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tenofovir disoproxil. The serum concentration of Netilmicin can be increased when it is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Droxicam is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Nafamostat is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Ferulic acid is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Tenofovir disoproxil. The serum concentration of Gentamicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Chlorzoxazone can be decreased when combined with Tenofovir disoproxil. The serum concentration of Plazomicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Thalidomide can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Salicylamide is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Parthenolide is combined with Tenofovir disoproxil. The metabolism of Temafloxacin can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Tolmetin is combined with Tenofovir disoproxil. The metabolism of Ulipristal can be decreased when combined with Tenofovir disoproxil. The metabolism of Chlorpromazine can be decreased when combined with Tenofovir disoproxil. The metabolism of Pyrazinamide can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Semapimod is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Higenamine is combined with Tenofovir disoproxil. The serum concentration of Zorubicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Estradiol can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Balsalazide is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Salsalate is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tenofovir disoproxil. The metabolism of Warfarin can be decreased when combined with Tenofovir disoproxil. The metabolism of Domperidone can be decreased when combined with Tenofovir disoproxil. The serum concentration of Tenofovir disoproxil can be increased when it is combined with Valganciclovir. The metabolism of Pimozide can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when PTC299 is combined with Tenofovir disoproxil. The metabolism of Mirtazapine can be decreased when combined with Tenofovir disoproxil. The serum concentration of Streptomycin can be increased when it is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Sulindac is combined with Tenofovir disoproxil. The serum concentration of Kanamycin can be increased when it is combined with Tenofovir disoproxil. The serum concentration of Tobramycin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Cilostazol can be decreased when combined with Tenofovir disoproxil. The metabolism of Promazine can be decreased when combined with Tenofovir disoproxil. The serum concentration of Atazanavir can be decreased when it is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Tenofovir disoproxil. The metabolism of Voxilaprevir can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Bucillamine is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Teriflunomide is combined with Tenofovir disoproxil. The metabolism of Thiabendazole can be decreased when combined with Tenofovir disoproxil. The metabolism of Clevidipine can be decreased when combined with Tenofovir disoproxil. The metabolism of Etoposide can be decreased when combined with Tenofovir disoproxil. The metabolism of Primaquine can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Naftifine is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Castanospermine is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Cobicistat is combined with Tenofovir disoproxil. The serum concentration of Sisomicin can be increased when it is combined with Tenofovir disoproxil. The metabolism of Omeprazole can be decreased when combined with Tenofovir disoproxil. The serum concentration of GENTAMICIN C1A can be increased when it is combined with Tenofovir disoproxil.